CBD and medical cannabis for epilepsy: the short answer

Exactly one cannabis-based medicine has FDA approval for epilepsy: purified cannabidiol, sold as Epidiolex. It contains plant-derived CBD with no meaningful THC, and it is cleared for seizures linked to Dravet syndrome, Lennox-Gastaut syndrome, and tuberous sclerosis complex. Those are three rare, stubborn, childhood-onset epilepsies. For everything else, including smoked flower, full-spectrum oils, and high-THC edibles, the human evidence is thin. That does not mean cannabis never helps someone with seizures. It means the proof is uneven, and the distance between "FDA approved" and "people swear by it" is wider here than in most corners of cannabis medicine.

How Medical Cannabis Helps Epilepsy

What the randomized trials measured

The approval rests on placebo-controlled trials published in the New England Journal of Medicine. In the Dravet trial, median monthly convulsive seizures dropped from about 12 to 6 on CBD, while the placebo group barely moved. In the Lennox-Gastaut trials, drop seizures fell by roughly 40 percent on CBD versus about 20 percent on placebo. Tuberous sclerosis trials showed a similar pattern.

read more

Read those numbers honestly. Some children responded a lot. Some responded a little. Some did not respond at all. A meaningful share of the benefit showed up in the placebo arms too, which is normal in epilepsy trials and a reminder of how much seizures fluctuate on their own.

Best Medical Cannabis Strains for Epilepsy: A Comparison Review

Why CBD and not THC

CBD does not work the way THC does. It is not a CB1 receptor agonist, so it does not produce a high, and its anti-seizure activity likely runs through other channels: adenosine signaling, GPR55, TRPV1, and effects on calcium channels. Researchers still do not have the full picture.

medical cannabis for epilepsy success stories

THC-rich cannabis has far weaker support. A handful of small trials, mostly in Israel, tested CBD-to-THC ratios in children with severe epilepsy. Some showed seizure reductions, but the studies were tiny, unblinded, or both. Most neurologists treat THC as a wildcard here: it can lower seizure threshold in some patients and help in others, and nobody can predict which group you land in.

How CBD is dosed in practice

Epidiolex comes as an oral solution, and the label is specific. Dosing is by body weight, not by drops or intuition.

For a 40-pound child, 10 mg per kg per day works out to roughly 180 mg daily, split into two doses. That is several times what a typical hemp bottle holds per serving, which is one reason store-bought CBD rarely matches prescription results.

Side effects and drug interactions

CBD is not benign. The most common problems in trials were sleepiness, decreased appetite, diarrhea, and fatigue. Liver enzyme elevations showed up often enough that the label calls for bloodwork before starting and periodically after, especially in the first months.

Interactions are the bigger deal. CBD is metabolized by CYP3A4 and CYP2C19, and it inhibits some of those same enzymes, so it can push up blood levels of clobazam's active metabolite, valproate, and other anticonvulsants. That can mean more seizure control, or more sedation and toxicity. Warfarin and transplant drugs are on the watch list too. Any doctor adding CBD to a regimen needs to know every other medication on board.

Hemp CBD, dispensary products, and prescription CBD

These are three different things and people mix them up constantly.

If a neurologist has already prescribed Epidiolex, that is the version to take. If you are considering a dispensary or hemp product instead, bring it to the neurologist first. Never swap a prescription anticonvulsant for an unregulated oil without medical supervision.

What to track if you try it

Keep a seizure diary with date, time, type, and duration. Note every dose change and the days after it. Log sleep, appetite, and mood, because those are where side effects show up first. Get baseline liver labs. Give any new regimen at least a few weeks before judging it, and give it months before calling it a failure. Responder status in the trials was measured over 12 to 14 weeks, not days.

The bottom line

For three specific epilepsy syndromes, CBD has real randomized evidence and FDA approval. For everything else, the honest answer is that we are still guessing, and the guessing should happen with a neurologist, not a checkout page.